Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -5.14% | -7.78% | +193.81% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
305M | - | |||||
728B | ||||||
603B | ||||||
360B | ||||||
332B | ||||||
279B |
- Stock Market
- Equities
- NKTR Stock
- Charts Nektar Therapeutics
- Sector Chart